ArticleScientific reports2023
Medium to long-term outcomes of medial patellofemoral ligament reconstruction using the superficial quadriceps versus a hamstring autograft in patellar instability patients.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.
- The incidence and epidemiology of patellar fractures following medial patellofemoral ligament reconstruction: a systematic review and meta-analysis.Archives of orthopaedic and trauma surgery · 2026Pooled it
- Superficial Quadriceps Versus Hamstring Tendon Grafts for Medial Patellofemoral Ligament Reconstruction: A 2-Center Comparative Study.Orthopaedic journal of sports medicine · 2026Article
- A retrospective Follow-Up after derotational distal femoral osteotomy combined with medial patellofemoral ligament reconstruction for the treatment of recurrent patellar dislocation.Journal of orthopaedic surgery and research · 2026Article
- Comparison of double bundle semitendinosus technique and pedicled quadriceps technique in patellar instability.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2025Article
- Arthroscopic Management of Patellar Instability in Skeletally Immature Patients: Current Concepts and Future Directions.Journal of clinical medicine · 2025Review
- Comparable outcomes between quadriceps and hamstring tendon autografts for isolated medial patellofemoral ligament reconstruction: A systematic review of studies with minimum 2-year follow-up.Journal of experimental orthopaedics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medial patellofemoral ligament (MPFL) reconstruction is a standard procedure in patellar dislocation patients. Superficial quadriceps autografts (QA) and hamstring autografts (HA) are popular graft choices in MPFL reconstruction with the lack of directly compared clinical studies between both methods. A total of 43 patellar instability patients, who underwent QA and HA for patellar stabilization at a specified center between 2012 and 2021, were retrospectively reviewed. 21 QA and 22 HA patients were 52.4% of males and 47.6% females with a median age of 25 years (range 12-58) in the QA group, while 63.6% were females with a median age of 21 years (range 14-58) in the HA group. The mean follow-up period was 46.9 months (range 24-77) in QA and 61 months (range 24-100) in the HA group. At the final follow-up, no complications were observed with either technique. No patients presented with recurrent dislocations after surgery. There was no statistically significant difference in postoperative mean Kujala scores (QA = 94.9+/- 4.1 and HA = 94.2+/- 8.0, p = 0.73) or the mean Lysholm scores (QA = 94.1+/- 5.0 and HA = 93.2+/- 7.0, p = 0.61).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.